Smiths Medical Launches Portex® EchoGlo® Peripheral Nerve Block Range
Smiths Medical, a leading medical device manufacturer, has launched its EchoGlo® peripheral nerve block range.
This addition to the Portex® portfolio of pain management products, offers customers a complete solution for regional anaesthesia from pump to patient.
The Portex® EchoGlo® needle has been engineered for echogenic brightness under ultrasound even at extreme angles, which can enhance visualization and accuracy in delivering medication. This proprietary technology helps clinicians to confidently place local anaesthetic, which may reduce post-operative dependency on opioids.
Glen Johnson, NordUK Senior Marketing Manager at Smiths Medical, says: “Smiths Medical is proud to offer EchoGlo® nerve block needles as part of our patient to pump solution. Combining the echogenic brightness of EchoGlo® products with our CADD® pump portfolio provides a full solution for our clinicians and patients.”
The launch of the full EchoGlo® range enables Smiths Medical to offer clinicians more solutions to treat their patients safely and effectively.
For more information on the new EchoGlo® range contact Glen Johnson, NordUK Senior Marketing Manager at Smiths Medical, on 01233 722 100, email [email protected] or visit www.smiths-medical.com/products/pain-management/peripheral-nerve-block--plexus-anesthesia/echoglo-peripheral-nerve-block-needle
Nanosonics is a global infection prevention innovator and inventor of trophon®2, a breakthrough disinfection technology which is setting the new standard of care globally for ultrasound probe reprocessing. trophon2 is an updated version of the popular trophon EPR device.